Linc AB (STO:LINC)

Market Cap	4.11B +4.3%
Revenue (ttm)	437.99M +103.8%
Net Income	419.45M +71.7%
EPS	7.24 +71.7%
Shares Out	57.91M
PE Ratio	9.80
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,728
Open	71.80
Previous Close	71.20
Day's Range	71.00 - 72.80
52-Week Range	58.90 - 83.60
Beta	0.70
Analysts	Hold
Price Target	71.00 (0.0%)
Earnings Date	Jul 17, 2026

About Linc AB

Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million ($2.99 million) and SEK 250 million ($29.9...

• Industry: Asset Management
• Sector: Financials
• Founded: 1991
• Employees: 2
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: LINC

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 15, 2026

Data Sources Report a data error